drugset / Trial / NCT01374698
Aspirin Reload Before Percutaneous Coronary Intervention: Reperfusion Indexes Evaluation.
RandomizedParallel-groupSingle-blindTreatment
Summary
This is a prospective, randomized study conducted in patients undergoing coronary revascularization procedures (PCI) through angioplasty. All patients who meet the eligibility criteria will be randomized to receive, before the procedure, an oral aspirin reload (325 mg) and to be re-evaluated at 60 minutes, 120 minutes, 6 hours, 48 hours, 5 and 30 day, 3 and 6 months.
Timeline
- Start
- 2011-01
- Primary completion
- 2011-09
- Completion
- 2012-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Aspirin | Small molecule | 325 mg | Oral |